{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:22:33Z","timestamp":1783408953479,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ajem.2021.03.061","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T02:07:30Z","timestamp":1616551650000},"page":"86-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Clinical effects of intravenous bupropion misuse reported to a regional poison center"],"prefix":"10.1016","volume":"47","author":[{"given":"Daniel J.","family":"McCabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"McGillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Willenbring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajem.2021.03.061_bb0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/jnci\/djr558","article-title":"Enhancing the effectiveness of smoking cessation interventions: a cancer prevention imperative","volume":"104","author":"Alberg","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ajem.2021.03.061_bb0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/03602532.2019.1620763","article-title":"Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects","volume":"51","author":"Costa","year":"2019","journal-title":"Drug Metab Rev"},{"issue":"9","key":"10.1016\/j.ajem.2021.03.061_bb0015","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/oby.2001.71","article-title":"Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women","volume":"9","author":"Gadde","year":"2001","journal-title":"Obes Res"},{"issue":"6","key":"10.1016\/j.ajem.2021.03.061_bb0020","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/JCP.0b013e3181c09475","article-title":"Abuse potential of bupropion nasal insufflation: a case report","volume":"29","author":"Langguth","year":"2009","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.ajem.2021.03.061_bb0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000335352","article-title":"Naltrexone\/bupropion: an investigational combination for weight loss and maintenance","volume":"4","author":"Makowski","year":"2011","journal-title":"Obes Facts"},{"issue":"2","key":"10.1016\/j.ajem.2021.03.061_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa2020214","article-title":"Bupropion and naltrexone in methamphetamine use disorder","volume":"384","author":"Trivedi","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajem.2021.03.061_bb0035","first-page":"256","article-title":"Seizures and bupropion: a review","volume":"50","author":"Davidson","year":"1989","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.ajem.2021.03.061_bb0040","first-page":"450","article-title":"A 102-center prospective study of seizure in association with bupropion","volume":"52","author":"Johnston","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ajem.2021.03.061_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/15563650.2018.1493205","article-title":"A 10-year review of single medication double-dose ingestions in the nation\u2019s largest poison control system","volume":"57","author":"Correia","year":"2019","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ajem.2021.03.061_bb0050","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/15563650.2013.829233","article-title":"Toxicology Investigators Consortium (ToxIC) Case Registry. Drug-induced seizures in children and adolescents presenting for emergency care: current and emerging trends","volume":"51","author":"Finkelstein","year":"2013","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ajem.2021.03.061_bb0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/15563650.2014.918627","article-title":"Seizures after single-agent overdose with pharmaceutical drugs: analysis of cases reported to a poison center","volume":"52","author":"Reichert","year":"2014","journal-title":"Clin Toxicol"},{"issue":"1","key":"10.1016\/j.ajem.2021.03.061_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13181-019-00738-7","article-title":"Pediatric bupropion ingestions in adolescents vs. younger children-a tale of two populations","volume":"16","author":"Offerman","year":"2020","journal-title":"J Med Toxicol"},{"issue":"10","key":"10.1016\/j.ajem.2021.03.061_bb0065","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1592\/phco.2005.25.10.1378","article-title":"Adverse effects associated with extra doses of bupropion","volume":"25","author":"Shepherd","year":"2005","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.ajem.2021.03.061_bb0070","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/15563650.2017.1377839","article-title":"Suicidal bupropion ingestions in adolescents: increased morbidity compared with other antidepressants","volume":"56","author":"Sheridan","year":"2018","journal-title":"Clin Toxicol"},{"issue":"5","key":"10.1016\/j.ajem.2021.03.061_bb0075","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ADM.0000000000000249","article-title":"Bupropion \u201cabuse\u201d reported to US poison centers","volume":"10","author":"Stassinos","year":"2016","journal-title":"J Addict Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.03.061_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03161033","article-title":"Evolving epidemiology of drug-induced seizures reported to a poison control center system","volume":"3","author":"Thundiyil","year":"2007","journal-title":"J Med Toxicol"},{"issue":"8","key":"10.1016\/j.ajem.2021.03.061_bb0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/15563650.2019.1699658","article-title":"Clinical characteristics and outcomes associated with bupropion overdose: a Canadian perspective","volume":"58","author":"Stewart","year":"2020","journal-title":"Clin Toxicol"},{"issue":"12","key":"10.1016\/j.ajem.2021.03.061_bb0090","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1080\/15563650.2020.1834219","article-title":"2019 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 37th annual report","volume":"58","author":"Gummin","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.ajem.2021.03.061_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2018-3295","article-title":"Toxicity of bupropion overdose compared with selective serotonin reuptake inhibitors","volume":"144","author":"Overberg","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajem.2021.03.061_bb0100","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3109\/15563650.2013.849349","article-title":"Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion","author":"Al-Abri","year":"2013","journal-title":"Clin Toxicol"},{"issue":"2","key":"10.1016\/j.ajem.2021.03.061_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5694\/j.1326-5377.2003.tb05064.x","article-title":"Bupropion poisoning: a case series","volume":"178","author":"Balit","year":"2003","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.ajem.2021.03.061_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0736-4679(02)00522-X","article-title":"Bupropion exposures: clinical manifestations and medical outcome","volume":"23","author":"Belson","year":"2002","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2021.03.061_bb0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cpem.2017.07.005","article-title":"Bupropion overdose: significant toxicity in pediatrics","volume":"18","author":"Brown","year":"2017","journal-title":"Clin Pediatr Emerg Med"},{"issue":"5","key":"10.1016\/j.ajem.2021.03.061_bb0120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1472-8206.2011.00953.x","article-title":"QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile","volume":"26","author":"Caillier","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ajem.2021.03.061_bb0125","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/15563650.2020.1746330","article-title":"Drug-specific risk of severe QT prolongation following acute drug overdose","volume":"58","author":"Campleman","year":"2020","journal-title":"Clin Toxicol"},{"issue":"3","key":"10.1016\/j.ajem.2021.03.061_bb0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jemermed.2005.01.027","article-title":"Intraventricular conduction delay after bupropion overdose","volume":"29","author":"Curry","year":"2005","journal-title":"J Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.03.061_bb0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MJT.0b013e3180a5bd83","article-title":"Bupropion-associated QRS prolongation unresponsive to sodium bicarbonate therapy","volume":"16","author":"Wills","year":"2009","journal-title":"Am J Ther"},{"issue":"8","key":"10.1016\/j.ajem.2021.03.061_bb0140","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ajem.2008.07.004","article-title":"Incidence and onset of delayed seizures after overdoses of extended-release bupropion","volume":"27","author":"Starr","year":"2009","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2021.03.061_bb0145","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/15563650.2020.1742919","article-title":"Bupropion associated seizures following acute overdose: who develops late seizures","volume":"58","author":"Offerman","year":"2020","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ajem.2021.03.061_bb0150","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/0004867416632928","article-title":"Have we underestimated the possibility of bupropion sustained-release addiction?","volume":"50","author":"Hu","year":"2016","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.ajem.2021.03.061_bb0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fphar.2018.00239","article-title":"Is there a potential of misuse for venlafaxine and bupropion?","volume":"9","author":"Schifano","year":"2018","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.ajem.2021.03.061_bb0160","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1007\/s00213-019-05337-6","article-title":"Bupropion increases activation in nucleus accumbens during anticipation of monetary reward","volume":"236","author":"Ikeda","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.ajem.2021.03.061_bb0165","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ADM.0000000000000044","article-title":"Intravenous administration and abuse of bupropion: a case report and a review of the literature","volume":"8","author":"Oppek","year":"2014","journal-title":"J Addict Med"},{"issue":"11","key":"10.1016\/j.ajem.2021.03.061_bb0170","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.ajem.2019.02.044","article-title":"Phenibut exposures and clinical effects reported to a regional poison center","volume":"37","author":"McCabe","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2021.03.061_bb0175","author":"AAPCC"},{"key":"10.1016\/j.ajem.2021.03.061_bb0180","series-title":"Merck Research Laboratories, Whitehouse Station, NJ","first-page":"246","author":"The Merck Index","year":"2006"},{"issue":"8","key":"10.1016\/j.ajem.2021.03.061_bb0185","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1080\/15563650701197096","article-title":"Unproven ingestion: an unrecognized bias in toxicological case series","volume":"45","author":"Levy","year":"2007","journal-title":"Clin Toxicol"},{"issue":"8","key":"10.1016\/j.ajem.2021.03.061_bb0190","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/15563650701233370","article-title":"Understanding the limitations of retrospective analyses of poison center data","volume":"45","author":"Hoffman","year":"2007","journal-title":"Clin Toxicol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721002485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721002485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:53:08Z","timestamp":1760025188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721002485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":38,"alternative-id":["S0735675721002485"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.03.061","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical effects of intravenous bupropion misuse reported to a regional poison center","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.03.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}